Cartalax caps #60

$60.50

  • Availability: In Stock

  • 2 or more $57.35
  • 3 or more $54.25

Indications
Osteochondrosis; osteoporosis; degenerative and dystrophic diseases of the joints; rheumatism; gout.
The course lasts 10-30 days (1-2 packs).

Recommended


- arthrosis and arthritis
- in osteochondrosis
- in osteoporosis
- degenerative-dystrophic diseases of joints, limbs and spine
- for rheumatism
- at consequences of injuries of joints and extremities
- in the arthropathy of various etiologies
- with gout
- for systemic prevention of bone and joint injuries in sports of higher achievements;
- systemic connective tissue diseases
- during the preoperative and postoperative periods during operations on the joints
- in conditions after extreme physical activity
- for the prevention of degenerative processes in the spine and joints in the elderly and senile.

Method of application


Adults take 1-2 capsules 1-2 times a day with meals. Duration of administration 10-30 days. It is advisable to repeat the course after 4-6 months.

When applying Cartalax no identified side effects, complications and drug dependence.

Store in a dry, dark place at room temperature.

Composition


Peptide complex as-4-(alanine, glutamic acid, aspartic acid). Excipients: microcrystalline cellulose (E460), beet sugar, lactose, starch, twin-80. As an additional source of peptides.

Contraindications


Individual intolerance of components, pregnancy, breast-feeding. It is recommended to consult a doctor before use.
Bioregulator of normalization of cartilage and musculoskeletal system function .

Cartalax is a peptide complex containing amino acids that contribute to the normalization of cartilage and musculoskeletal system.

In a clinical study the effectiveness of Cartalax in comprehensive prevention and treatment of patients suffering from spinal osteochondrosis, osteoarthritis, osteoporosis, after injuries and fractures, as well as in the prevention of sclerotic and degenerative processes in the spine and joints in elderly and senile age.

It is possible to use Cartalax to reduce pain and increase the volume of movements in the affected joints.

Cartalax it is recommended to take 1-2 capsules 1-2 times a day during meals. The length of treatment is 20-30 days. It is advisable to repeat the course after 4-6 months.

The clinical study of the effectiveness of Cartalax was attended by 63 patients diagnosed with "Osteoarthritis of the knee joints" (18 people, including 11 men, 7 women)," Osteochondrosis of the spine "(28 people, including 12 men, 16 women)," Osteoporosis " (17 women) aged 45 to 78 years, which made up the main group.

Patients with osteoarthritis of the knee joints complained of pain and restriction of flexion and extension in the joints when walking. In the older age group, the characteristic signs were joint deformation, atrophy of the femoral muscles and weakening of the ligamentous apparatus of the joints.

Patients with osteochondrosis of the spine often noted the appearance of pain in the lower back with irradiation of the sciatic nerve, which significantly increases when changing the position of the body, walking, physical activity, as well as pain in the thoracic spine. Osteoporosis patients complained of frequent bone fractures occurring with minor trauma or even without apparent cause. In patients of the main and control groups, the duration of the disease was from 5 to 20 years and there was a progressive dynamics of the pathological process.

All patients had previously received analgesics and anti-inflammatory drugs for a long time, the use of which caused a short-term therapeutic effect, requiring an increase in the dose of drugs for the course of treatment and prolonged administration.

Patients of the control group were treated with conventional drugs. Patients of the main group in addition to conventional drugs appointed Cartalax 1-2 capsules 2-3 times a day with meals for 20— 30 days.

To assess the effectiveness of the use of Cartalax, the dynamics of patients ' complaints was analyzed, as well as objective indicators: General clinical study of blood and urine, biochemical blood analysis, radiography.

It should be noted that the x-ray symptoms of degenerative diseases of the joints and spine are not only objective diagnostic criteria of the stage of development of the pathological process, but also have great prognostic significance in the ongoing drug therapy.

It was found that the use of Cartalax in patients with osteoarthritis of the knee joints contributed to the reduction of pain and increased joint mobility in 72.6% of cases. The most full of pain symptoms disappeared when radiologically-defined early stages of the disease: narrowing of the joint space between the patella and the femur, lateral osteophytes of the patella and femoral condyle. Significant dynamics of radiological symptoms in this period was not observed. In patients in the advanced stage of arthrosis, a similar but less pronounced dynamics of subjective indicators was observed. Since this stage of the disease was diagnosed in the older age group, such subjective feelings were characterized as very favorable. In patients with osteochondrosis of the lumbar spine, the use of Cartalax on the background of complex therapy contributed to the reduction of pain syndrome in 65.3% of cases. Such dynamics were most typical for middle-aged people. In persons of older age groups, the use of Cartalax for 20-30 days smoothed the pain symptoms progressive with age, arising from the load on the spine and lower limbs, and contributed to an increase in the mobility of the spine. In patients with osteoporosis with prolonged use of the drug (at least 3 courses per year-30 days each with an interval of 4 months), stabilization of metabolic processes in bone tissue was observed, confirmed by densitometric studies: the number of characteristic fractures decreased, the process of restoring the function of the musculoskeletal system was significantly accelerated and the time of stay in the hospital decreased. In all patients, there was a significant smoothing of the main symptoms of these diseases, characterized by significant conservatism.